These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 6834618)

  • 1. Oral contraceptive use and the occurrence of pituitary prolactinoma.
    Shy KK; McTiernan AM; Daling JR; Weiss NS
    JAMA; 1983 Apr 22-29; 249(16):2204-7. PubMed ID: 6834618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preferred frequency and characteristics of menstrual bleeding in relation to reproductive status, oral contraceptive use, and hormone replacement therapy use.
    den Tonkelaar I; Oddens BJ
    Contraception; 1999 Jun; 59(6):357-62. PubMed ID: 10518229
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral contraceptives and prolactinomas: a case-control study.
    Maheux R; Jenicek M; Cleroux R; Beauregard H; De Muylder X; Gratton NM; Van Campenhout J
    Am J Obstet Gynecol; 1982 May; 143(2):134-8. PubMed ID: 7081323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Permanent alterations induced in plasma prolactin and estrogen receptor concentration in benign and malignant tissue of women who started oral contraceptive use at an early age.
    Olsson H; Lindahl B; Ranstam J; Borg A; Fernö M; Norgren A
    Anticancer Res; 1987; 7(4B):853-6. PubMed ID: 3674773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive use after conception in relation to the risk of congenital urinary tract anomalies.
    Li DK; Daling JR; Mueller BA; Hickok DE; Fantel AG; Weiss NS
    Teratology; 1995 Jan; 51(1):30-6. PubMed ID: 7597655
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oral contraceptive risks: a realistic appraisal.
    Bressler R; Durand JL
    Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Oral contraceptives and prolactin-producing hypophyseal tumors].
    Lamberts SW
    Ned Tijdschr Geneeskd; 1980 Jan; 124(4):111-3. PubMed ID: 7374834
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Fertility and characteristics of ovulation after discontinuing oral contraception].
    Gaspard U; Lambotte R
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1005-10. PubMed ID: 12266509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
    Kay CR
    Clin Obstet Gynaecol; 1984 Dec; 11(3):759-86. PubMed ID: 6509858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two studies find no link between use of oral contraceptives and development of pituitary tumors.
    Fam Plann Perspect; 1983; 15(6):283-4. PubMed ID: 6667737
    [No Abstract]   [Full Text] [Related]  

  • 11. [Use of the pill by adolescents for contraception or as therapy].
    van Hooff MH; Hirasing RA; Kaptein M; Koppenaal C; Voorhorst FJ; Schoemaker J
    Ned Tijdschr Geneeskd; 1995 Jan; 139(4):178-82. PubMed ID: 7845497
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Morphofunctional features of the cervix uteri in women using hormonal contraception].
    Prilepskaia VN; Kondrikov NI; Nazarova NM
    Akush Ginekol (Mosk); 1991 Dec; (12):6-10. PubMed ID: 1789353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The "other" advantages of the pill].
    Meuwissen JH
    Ned Tijdschr Geneeskd; 1983 Jul; 127(29):1294-6. PubMed ID: 6888595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective screening for the Factor V Leiden mutation: is it advisable prior to the prescription of oral contraceptives?
    Schambeck CM; Schwender S; Haubitz I; Geisen UE; Grossmann RE; Keller F
    Thromb Haemost; 1997 Dec; 78(6):1480-3. PubMed ID: 9423798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The prolactinoma problem.
    Reichlin S
    N Engl J Med; 1979 Feb; 300(6):313-5. PubMed ID: 759885
    [No Abstract]   [Full Text] [Related]  

  • 16. Weighing the evidence on the pill and breast cancer.
    Johnson JH
    Fam Plann Perspect; 1989; 21(2):89-92. PubMed ID: 2653859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Oral contraceptive use and the risk of cancer].
    Wingo PA
    Fertil Contracept Sex; 1989 Feb; 17(2):125-32. PubMed ID: 12281877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pregnancies in reliable pill takers.
    Sparrow MJ
    N Z Med J; 1989 Nov; 102(879):575-7. PubMed ID: 2812591
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of long-term postoperative oral contraceptive use for the prevention of endometrioma recurrence on bone mineral density in young women.
    Lee DY; Oh YK; Yoon BK; Choi D
    Gynecol Endocrinol; 2014 Oct; 30(10):751-4. PubMed ID: 24927075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin response to dopamine synthesis inhibition using monoiodotyrosine in subjects on oral contraceptives and patients with pathological hyperprolactinemia.
    Ho KY; Smythe GA; Lazarus L
    J Clin Endocrinol Metab; 1983 Apr; 56(4):692-6. PubMed ID: 6833458
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.